INFI Annual Operating Expenses
$45.87 M
+$53.00 K+0.12%
31 December 2022
Summary:
As of January 21, 2025, INFI annual total operating expenses is $45.87 million, with the most recent change of +$53.00 thousand (+0.12%) on December 31, 2022. During the last 3 years, it has risen by +$4.47 million (+10.79%).INFI Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
INFI Quarterly Operating Expenses
$10.35 M
-$1.45 M-12.26%
30 June 2023
Summary:
As of January 21, 2025, INFI quarterly total operating expenses is $10.35 million, with the most recent change of -$1.45 million (-12.26%) on June 30, 2023. Over the past year, it has dropped by -$1.94 million (-15.78%).INFI Quarterly Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
INFI Operating Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +0.1% | -15.8% |
| 3 y3 years | +10.8% | +14.2% |
| 5 y5 years | +8.1% | +45.1% |
INFI Operating Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | ||||
| 5 y | 5-year | ||||
| alltime | all time | -80.6% | -89.3% |
Infinity Pharmaceuticals Operating Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| June 2023 | - | $10.35 M(-12.3%) |
| Mar 2023 | - | $11.80 M(+20.9%) |
| Dec 2022 | $45.87 M(+0.1%) | $9.75 M(-12.6%) |
| Sept 2022 | - | $11.16 M(-9.2%) |
| June 2022 | - | $12.29 M(-3.0%) |
| Mar 2022 | - | $12.67 M(+8.5%) |
| Dec 2021 | $45.82 M(+17.0%) | $11.68 M(+7.0%) |
| Sept 2021 | - | $10.92 M(-4.7%) |
| June 2021 | - | $11.46 M(-2.7%) |
| Mar 2021 | - | $11.77 M(+13.1%) |
| Dec 2020 | $39.18 M(-5.4%) | $10.41 M(+15.1%) |
| Sept 2020 | - | $9.04 M(-0.2%) |
| June 2020 | - | $9.06 M(-15.1%) |
| Mar 2020 | - | $10.67 M(-8.6%) |
| Dec 2019 | $41.41 M(+21.8%) | $11.68 M(+9.0%) |
| Sept 2019 | - | $10.72 M(+8.8%) |
| June 2019 | - | $9.85 M(+7.5%) |
| Mar 2019 | - | $9.16 M(+7.4%) |
| Dec 2018 | $34.01 M(-19.9%) | $8.53 M(-3.3%) |
| Sept 2018 | - | $8.82 M(+23.6%) |
| June 2018 | - | $7.13 M(-25.0%) |
| Mar 2018 | - | $9.52 M(+18.7%) |
| Dec 2017 | $42.45 M(-73.8%) | $8.02 M(-42.1%) |
| Sept 2017 | - | $13.84 M(+37.0%) |
| June 2017 | - | $10.11 M(-3.5%) |
| Mar 2017 | - | $10.48 M(-54.9%) |
| Dec 2016 | $161.83 M(-31.5%) | $23.23 M(+16.5%) |
| Sept 2016 | - | $19.93 M(-71.0%) |
| June 2016 | - | $68.64 M(+37.2%) |
| Mar 2016 | - | $50.02 M(+3.7%) |
| Dec 2015 | $236.17 M(+36.6%) | $48.24 M(+1.6%) |
| Sept 2015 | - | $47.48 M(+9.2%) |
| June 2015 | - | $43.47 M(-55.2%) |
| Mar 2015 | - | $96.98 M(+123.1%) |
| Dec 2014 | $172.92 M(+35.4%) | $43.46 M(-17.9%) |
| Sept 2014 | - | $52.94 M(+50.3%) |
| June 2014 | - | $35.22 M(-14.7%) |
| Mar 2014 | - | $41.30 M(+24.8%) |
| Dec 2013 | $127.68 M(-12.7%) | $33.08 M(-3.2%) |
| Sept 2013 | - | $34.18 M(+4.3%) |
| June 2013 | - | $32.76 M(+18.4%) |
| Mar 2013 | - | $27.66 M(-41.3%) |
| Dec 2012 | $146.28 M(+11.4%) | $47.13 M(+69.6%) |
| Sept 2012 | - | $27.79 M(-22.8%) |
| June 2012 | - | $36.01 M(+1.8%) |
| Mar 2012 | - | $35.36 M(-1.6%) |
| Dec 2011 | $131.30 M | $35.94 M(+3.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2011 | - | $34.89 M(+11.4%) |
| June 2011 | - | $31.32 M(+7.4%) |
| Mar 2011 | - | $29.15 M(+6.1%) |
| Dec 2010 | $119.57 M(+22.9%) | $27.47 M(-37.2%) |
| Sept 2010 | - | $43.75 M(+80.6%) |
| June 2010 | - | $24.23 M(+0.4%) |
| Mar 2010 | - | $24.13 M(+13.4%) |
| Dec 2009 | $97.31 M(+51.3%) | $21.28 M(-7.8%) |
| Sept 2009 | - | $23.07 M(-12.6%) |
| June 2009 | - | $26.39 M(-0.7%) |
| Mar 2009 | - | $26.57 M(+20.6%) |
| Dec 2008 | $64.30 M(+34.4%) | $22.04 M(+42.1%) |
| Sept 2008 | - | $15.51 M(+7.3%) |
| June 2008 | - | $14.46 M(+17.6%) |
| Mar 2008 | - | $12.29 M(-15.6%) |
| Dec 2007 | $47.83 M(+5.7%) | $14.57 M(+31.7%) |
| Sept 2007 | - | $11.07 M(-3.1%) |
| June 2007 | - | $11.42 M(+6.1%) |
| Mar 2007 | - | $10.77 M(-15.0%) |
| Dec 2006 | $45.26 M(+22.3%) | $12.67 M(+18.2%) |
| Sept 2006 | - | $10.72 M(+5.0%) |
| June 2006 | - | $10.21 M(-12.4%) |
| Mar 2006 | - | $11.65 M(+12.6%) |
| Dec 2005 | $36.99 M(+9.8%) | $10.35 M(+8.0%) |
| Sept 2005 | - | $9.58 M(+265.7%) |
| June 2005 | - | $2.62 M(-55.8%) |
| Mar 2005 | - | $5.93 M(-68.9%) |
| Dec 2004 | $33.69 M(+97.8%) | $19.08 M(+256.3%) |
| Sept 2004 | - | $5.35 M(+15.6%) |
| June 2004 | - | $4.63 M(+0.1%) |
| Mar 2004 | - | $4.63 M(-6.0%) |
| Dec 2003 | $17.03 M(-75.7%) | $4.92 M(+20.5%) |
| Sept 2003 | - | $4.08 M(-1.3%) |
| June 2003 | - | $4.14 M(+7.1%) |
| Mar 2003 | - | $3.86 M(-92.9%) |
| Dec 2002 | $70.21 M(+127.0%) | $54.72 M(+1002.5%) |
| Sept 2002 | - | $4.96 M(-3.1%) |
| June 2002 | - | $5.12 M(-5.3%) |
| Mar 2002 | - | $5.41 M(-57.9%) |
| Dec 2001 | $30.92 M(+1.2%) | $12.84 M(+71.9%) |
| Sept 2001 | - | $7.47 M(+1.3%) |
| June 2001 | - | $7.37 M(-13.4%) |
| Mar 2001 | - | $8.51 M(-46.9%) |
| Dec 2000 | $30.55 M(+253.2%) | $16.05 M(+139.2%) |
| Sept 2000 | - | $6.71 M(+11.2%) |
| June 2000 | - | $6.03 M(+100.4%) |
| Mar 2000 | - | $3.01 M |
| Dec 1999 | $8.65 M | - |
FAQ
- What is Infinity Pharmaceuticals annual total operating expenses?
- What is the all time high annual operating expenses for Infinity Pharmaceuticals?
- What is Infinity Pharmaceuticals annual operating expenses year-on-year change?
- What is Infinity Pharmaceuticals quarterly total operating expenses?
- What is the all time high quarterly operating expenses for Infinity Pharmaceuticals?
- What is Infinity Pharmaceuticals quarterly operating expenses year-on-year change?
What is Infinity Pharmaceuticals annual total operating expenses?
The current annual operating expenses of INFI is $45.87 M
What is the all time high annual operating expenses for Infinity Pharmaceuticals?
Infinity Pharmaceuticals all-time high annual total operating expenses is $236.17 M
What is Infinity Pharmaceuticals annual operating expenses year-on-year change?
Over the past year, INFI annual total operating expenses has changed by +$53.00 K (+0.12%)
What is Infinity Pharmaceuticals quarterly total operating expenses?
The current quarterly operating expenses of INFI is $10.35 M
What is the all time high quarterly operating expenses for Infinity Pharmaceuticals?
Infinity Pharmaceuticals all-time high quarterly total operating expenses is $96.98 M
What is Infinity Pharmaceuticals quarterly operating expenses year-on-year change?
Over the past year, INFI quarterly total operating expenses has changed by -$1.94 M (-15.78%)